#𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐢𝐬 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐢𝐭𝐬 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐄𝐒𝐌𝐎 𝐢𝐧 𝐁𝐚𝐫𝐜𝐞𝐥𝐨𝐧𝐚, 𝐒𝐩𝐚𝐢𝐧 𝐟𝐫𝐨𝐦 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟏𝟑𝐭𝐡 𝐭𝐨 𝟏𝟕𝐭𝐡! Meet Delpharm Business Developers to discover our cutting-edge services in high potent drug product development, manufacturing and packaging. From early-stage formulation to commercial manufacturing, Delpharm team specializes in finding tailor-made solutions for your projects. 📅 Plan a meeting here to learn how we can support your next breakthrough. https://lnkd.in/dzUqUaV Let's collaborate to bring life-changing therapies to patients around the globe! #ESMO #DrugDevelopment #CDMO
Delpharm
Pharmaceutical Manufacturing
A worldwide leader in contract development and manufacturing of medicines
About us
Delpharm is a leading CDMO : - 19 plants in France, Italy, Canada, Poland and The Netherlands - Over 1,1 billion euros turnover - 6,500 people working in the company - Most dosage forms produced For over 35 years, Delpharm has built up its position by acquiring manufacturing plants over the years, in particular from big pharmaceutical companies. As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules. Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.
- Website
-
http://www.delpharm.com/en/
External link for Delpharm
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Boulogne-Billancourt
- Type
- Privately Held
- Specialties
- CMO, PHARMACEUTICAL DRUG, SOLID FORM, LIQUID FORM, SEMI SOLID FORM, CDMO, HORMONE, ONCOLOGY, STERILE, SERIALIZATIUON, SERIALISATION, FABRICATION MEDICAMENT, FDA, PMDA, ANVISA, DRUG MANUFACTURING, DRUG PLANT, DRUG DEVELOPMENT, SOFTGEL, and REGULATORY
Locations
Employees at Delpharm
Updates
-
As a major CDMO, #Delpharm is proud be among the first three PSCI - Pharmaceutical Supply Chain Initiative Supplier Partner. This shows Delpharm’s commitment to improve its global supply chain sustainability towards its clients and patients. “Delpharm believes that every company has a key role to play in making a difference and driving responsible value chain practices. Becoming a Supplier Partner demonstrates Delpharm’s commitment to drive excellence in safety, environmental, and social outcomes within our company and across the global pharmaceutical and healthcare supply chain.” Nicolas Ragot, Managing Director at Delpharm #CDMO #Sustainability #PSCI
-
-
[𝐌𝐞𝐞𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐒𝐲𝐧𝐞𝐫𝐠𝐲 𝐎𝐓𝐂] #Delpharm will be at Pharma Synergy OTC 2024 from September 12th to 13th in Paris. We will be pleased to meet you and to discuss your manufacturing OTC projects. 📅 Book a meeting here: https://lnkd.in/dzUqUaV #CDMO ##PharmaSynergyOTC
-
-
𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐢𝐥𝐥𝐢𝐧𝐠 𝐰𝐨𝐫𝐤𝐬𝐡𝐨𝐩 𝐝𝐞𝐝𝐢𝐜𝐚𝐭𝐞𝐝 𝐟𝐨𝐫 𝐲𝐨𝐮𝐫 𝐧𝐞𝐱𝐭 𝐩𝐫𝐞𝐟𝐢𝐥𝐥𝐞𝐝 𝐬𝐲𝐫𝐢𝐧𝐠𝐞𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭. This state-of-the-art line with isolator technology will produce between 25 and 30 million syringes per year, in 1 to 3 ml sizes. 👉 Contact us: https://lnkd.in/dzUqUaV
-
[Meet Delpharm at CPhI Worldwide 2024] #Delpharm will be in CPhI Worldwide 2024 from October 8th to 10th, in Milan. We will be please to host you in our booth and to discuss your development and manufacturing projects. 𝐕𝐢𝐬𝐢𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐛𝐨𝐨𝐭𝐡: 𝟓𝐂𝟏 📅 Book a meeting with our sales teams with your existing contact or through Delpharm website: https://lnkd.in/dwn_qsp #CPHIMilan #healthcare
-
🔬 𝐏𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 At #Delpharm, we understand the crucial importance of treatments tailored for children. Our team of experts is dedicated and experienced in the formulation, analytical development and validation and clinical batch manufacturing for innovative and safe paediatric treatments. 💡 𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐦𝐞𝐚𝐧? 1. 𝐌𝐢𝐧𝐢 𝐓𝐚𝐛𝐥𝐞𝐭𝐬, 𝐩𝐨𝐰𝐝𝐞𝐫𝐬, 𝐠𝐫𝐚𝐧𝐮𝐥𝐞𝐬, with a precise dosing 2. 𝐅𝐚𝐬𝐭 𝐝𝐢𝐬𝐬𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐚𝐛𝐥𝐞𝐭𝐬 to be taken with food (yogurts, fruit compote…) 3. 𝐋𝐢𝐪𝐮𝐢𝐝𝐬 with personalized dosage thanks to pipette administration 4. 𝐓𝐚𝐬𝐭𝐞 𝐦𝐚𝐬𝐤𝐢𝐧𝐠 𝐨𝐟 𝐛𝐢𝐭𝐭𝐞𝐫 𝐀𝐏𝐈 thanks to flavouring and colouring agents 5. 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞𝐬 for cases requiring immediate intervention or specific needs. With rigorous processes and recognized expertise, we are committed to provide therapeutic solutions that meet the specific needs of young and elderly patients. 🔗 Learn more: https://lnkd.in/dzUqUaV #CDMO #Drugdevelopment
-
-
𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 𝐬𝐚𝐭𝐢𝐬𝐟𝐢𝐞𝐬 𝐭𝐡𝐞 𝐆𝐫𝐨𝐮𝐩'𝐬 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬: "𝐀𝐧 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐟𝐨𝐫 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦” Since the beginning of 2024, Delpharm employees who had completed face-to-face training rated a global satisfaction rate of 4.7/5. 𝑊ℎ𝑎𝑡 𝑚𝑎𝑘𝑒𝑠 𝑡ℎ𝑒 𝐷𝑒𝑙𝑝ℎ𝑎𝑟𝑚 𝐴𝑐𝑎𝑑𝑒𝑚𝑦 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡? During training sessions, participants have the opportunity to exchange and meet colleagues from other site and to follow training tailored to their needs. #humanresources #Delpharm #pharmaceuticals
-
-
[The prefilled syringes workshop through the eyes of #Delpharm employees] The implementation of the prefilled syringes workshop on the DELPHARM TOURS site was made possible by the talented people that worked on the project. Sylvie, Line Manager, in particular, worked in the project team thanks to her expertise in packaging. Her knowledge of the processes involved was an asset for the documentation phase, technical tests, coordination of operations and the ergonomics of the space. Sylvie joined Delpharm Tours for its positive dynamic and ambitious projects: "Participating in the creation of a new workshop was an opportunity to be seized". Sylvie continues to see her future at Delpharm and looks forward to continuing to learn and share her experience! #innovation #healthcare #storytelling
-
-
Delpharm reposted this
𝗘𝘁 𝘀𝗶 𝗹’𝗼𝗻 𝘃𝗮𝗹𝗼𝗿𝗶𝘀𝗮𝗶𝘁 𝗹𝗲 « 𝗙𝗮𝗯𝗿𝗶𝗾𝘂𝗲́ 𝗲𝗻 𝗙𝗿𝗮𝗻𝗰𝗲 » 𝗱𝗲 𝗻𝗼𝘀 𝗺𝗲́𝗱𝗶𝗰𝗮𝗺𝗲𝗻𝘁𝘀 ? C’est l’une des 10 recommandations que nous portons 👇 Nous avons fait le choix stratégique du « Fabriqué en France ». Pour autant, nos TPE-PME et ETI de la filière du médicament en France sont en grande difficulté. Dans ce carrousel, découvrez nos 10 recommandations pour : ➡️ Continuer à verdir notre industrie ➡️ Avoir un prix juste qui tienne compte de notre « Fabriqué en France » ➡️ Maintenir la production de médicaments en France L’enjeu ? ✅ Garantir l’accessibilité des médicaments aux patients en France ✅ S’inscrire dans une perspective durable au service de la souveraineté sanitaire et industrielle de la France 👉 Lisez notre tribune pour sauver notre filière industrielle du médicament en France (page 6 de Pharmaceutiques - Juin-Juillet 2024) 🔗 https://lnkd.in/eMQqBcQj 👉 Prêts à soutenir notre mouvement ? Likez, commentez et partagez ce post SICOS (chimie fine & biotech) CDMO France AMLIS METI - Mouvement des Entreprises de Taille Intermédiaire karine PINON Vincent Touraille Laure Lechertier #tribune #santé #madeinfrance #industrie ** Entreprises du SICOS, de CDMO France, de l’AMLIS et du METI, nous produisons en France 35% des médicaments essentiels du quotidien et employons 50 000 collaborateurs sur nos 130 sites industriels.
-
Discover our full Annex 1 compliance workshop for your prefilled syringes project. For more information contact us here: https://lnkd.in/dzUqUaV #Delpharm #healthcare #innovation